Pharmaceuticals that contain polycyclic hydrocarbon scaffolds

Chemical Society Reviews
Tegan P Stockdale, Craig M Williams


Numerous variations on structural motifs exist within pharmaceutical compounds that have entered the clinic. These variations have amounted over many decades based on years of drug development associated with screening natural products and de novo synthetic systems. Caged (or bridged) bicyclic structural elements offer a variety of diverse features, encompassing three-dimensional shape, and assorted pharmacokinetic properties. This review highlights approximately 20 all carbon cage containing pharmaceuticals, ranging in structure from bicyclo[2.2.1] through to adamantane, including some in the top-selling pharmaceutical bracket. Although, a wide variety of human diseases, illnesses and conditions are treated with drugs containing the bicyclic motif, a common feature is that many of these lipophilic systems display CNS and/or neurological activity. In addition, to an extensive overview of the history and biology associated with each drug, a survey of synthetic methods used to construct these entities is presented. An analysis section compares natural products to synthetics in drug discovery, and entertains the classical caged hydrocarbon systems potentially missing from the clinic. Lastly, this unprecedented review is highly per...Continue Reading


Feb 9, 2016·Journal of Natural Products·David J Newman, Gordon M Cragg
Mar 17, 2015·Australian Health Review : a Publication of the Australian Hospital Association·Elizabeth H SkinnerTerry P Haines
Apr 28, 2016·Chemical Reviews·Markus D KärkäsCorey R J Stephenson
Jul 9, 2016·Magnetic Resonance in Chemistry : MRC·Gabriela da Costa Resende, Elson Santiago Alvarenga
Aug 16, 2016·Organic Letters·John A MilliganPeter Wipf
Feb 6, 2016·Angewandte Chemie·Benjamin A ChalmersCraig M Williams
Jun 20, 2017·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·P BrinkmanN Fens
Mar 1, 2018·Chemistry : a European Journal·Marta LarrosaRadim Hrdina
Jul 30, 2016·Chemical Communications : Chem Comm·Guohua WangJing Peng
Jan 16, 2019·Organic & Biomolecular Chemistry·Sevan D HoustonCraig M Williams
Feb 12, 2019·Chemistry : a European Journal·Keith J FlanaganMathias O Senge
Sep 13, 2019·Chemical Communications : Chem Comm·Kasun S Athukorala ArachchigeCraig M Williams
Feb 11, 2020·Current Pharmaceutical Design·Vasiliki PardaliGrigoris Zoidis
Jun 26, 2020·Organic & Biomolecular Chemistry·Benjamin ZonkerRadim Hrdina
Jan 27, 2019·Chemistry : a European Journal·Hui XingCraig M Williams
Nov 18, 2018·Nature Communications·Mateusz P PlesniakDavid J Procter
Jun 27, 2019·Organic & Biomolecular Chemistry·Sevan D HoustonCraig M Williams
Oct 21, 2020·Dalton Transactions : an International Journal of Inorganic Chemistry·Vladyslav V BakhonskyPeter R Schreiner


Sep 1, 1978·Anesthesia and Analgesia·R J Fragen, N Caldwell
Oct 1, 1976·Contact Dermatitis·D Fanta, P Mischer
Jul 1, 1979·Journal of Clinical Pharmacology·M Staquet
Apr 1, 1976·Journal of Medicinal Chemistry·M E FreedS C Bell
May 1, 1975·Antimicrobial Agents and Chemotherapy·J DrewsJ Unger
Apr 1, 1976·Journal of Medicinal Chemistry·M E FreedS C Bell
Jan 1, 1992·Drugs·S KasperH J Möller
Jan 1, 1992·Drugs·F de Jonghe, J A Swinkels
Jan 1, 1990·General Pharmacology·R Delucia, C da S Planeta
Oct 19, 1990·The Medical Letter on Drugs and Therapeutics
Jan 1, 1991·Chirality·E NusserJ Gal
Aug 3, 1989·European Journal of Pharmacology·J Bormann
Jul 7, 1988·Biochimica Et Biophysica Acta·K S RosenthalB G Barisas
Sep 1, 1985·Pharmacology, Biochemistry, and Behavior·M E RisnerE J Cone
Nov 1, 1985·Clinical Pharmacology and Therapeutics·D R Jasinski, K L Preston
Sep 1, 1985·Biomedical Mass Spectrometry·C KöppelF Klaschka
Jan 1, 1986·Progress in Neuro-psychopharmacology & Biological Psychiatry·W W FleischhackerH Schubert
May 1, 1986·Southern Medical Journal·B T FinucaneD J Petro
Jul 1, 1973·European Journal of Pharmacology·A C Sayers, S L Handley
Jun 1, 1973·Journal of Medicinal Chemistry·M E FreedJ L Malis
Jun 1, 1971·Journal of Medicinal Chemistry·P E AldrichJ C Watts
May 29, 1971·British Medical Journal·R C HughesJ N Walton
May 19, 1969·JAMA : the Journal of the American Medical Association·R S SchwabR R Young
Jan 1, 1969·Helvetica Chimica Acta·M Wilhelm, P Schmidt
Sep 1, 1965·Journal of Medicinal Chemistry·R T RapalaK Gerzon
Aug 1, 1981·Drugs·L E Hollister
Dec 1, 1984·Anesthesiology·T J Gal, C A DiFazio
Jan 1, 1984·General Pharmacology·R DeluciaM L Aizenstein
Jun 1, 1982·Drugs·P Crome
Dec 1, 1982·Antimicrobial Agents and Chemotherapy·K S RosenthalR C Fort
Feb 25, 1984·British Medical Journal·K Knudsen, A Heath
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·M L AizensteinR Delucia

Related Concepts

Drug Development
Natural Products
Caged molecule
Pharmacologic Substance
Mental Disorders
Drug Interactions

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.

Related Papers

Journal of Evolutionary Biology
B Walsh
Delaware Medical Journal
Darrin Campo
Acta Crystallographica. Section C, Crystal Structure Communications
Christopher S Frampton
© 2020 Meta ULC. All rights reserved